Addressing the Diagnostic Gap: The Need for Customised IVD Solutions for Rare Diseases
Time: 12:00 pm
day: Day 2 - Track A (1)
Details:
- Navigating the IVD landscape for rare diseases: Exploring strategies for addressing the challenges faced when IVDs are unavailable
- Market considerations: Discussing the implications of CE marking termination on IVD development.
- Assay validation considerations: Examining the complexities of cross-validation of assays across regions and the difference between validating biomarker assays used for exploratory vs diagnostic purposes
